Back to search

Article

A four‐gene‐based model predicts TACE efficacy for hepatocellular carcinoma patients

2022-03-03

Abstract excerpt

<h4>Background: </h4> Primary liver cancer, of which hepatocellular carcinoma (HCC) accounts for over 90%, is the sixth most common cancer and the fifth leading cause of cancer mortality worldwide. Transcatheter arterial chemoembolization (TACE) is widely performed globally as an effective treatment for HCC patients at intermediate and advanced stages, but the efficiency varies amongst patients. Objective This st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
165085e0-3098-53da-8277-29f91eb9d247
DOI
10.21203/rs.3.rs-1353233/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A four‐gene‐based model predicts TACE efficacy for hepatocellular carcinoma patientsDOI 10.21203/rs.3.rs-1353233/v1
Select a neighboring publication to make it the new centre.